Karin Stiasny Selected Research

Tick-Borne Encephalitis (Encephalitis, Tick Borne)

8/2021	Tick-Borne Encephalitis Specific Lymphocyte Response after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Humoral Immunity after Vaccination.
1/2021	Dynamics and Extent of Non-Structural Protein 1-Antibody Responses in Tick-Borne Encephalitis Vaccination Breakthroughs and Unvaccinated Patients.
1/2020	Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humans.
1/2020	Obesity and Sex Affect the Immune Responses to Tick-Borne Encephalitis Booster Vaccination.
1/2020	Extensive flavivirus E trimer breathing accompanies stem zippering of the post-fusion hairpin.
11/2018	Allergic patients with and without allergen-specific immunotherapy mount protective immune responses to tick-borne encephalitis vaccination in absence of enhanced side effects or propagation of their Th2 bias.
8/2015	Immunization with Immune Complexes Modulates the Fine Specificity of Antibody Responses to a Flavivirus Antigen.
11/2013	Aluminum hydroxide influences not only the extent but also the fine specificity and functional activity of antibody responses to tick-borne encephalitis virus in mice.
9/2013	Tick-borne encephalitis (TBE) and hepatitis B nonresponders feature different immunologic mechanisms in response to TBE and influenza vaccination with involvement of regulatory T and B cells and IL-10.
4/2013	Mechanistic insights into the impairment of memory B cells and antibody production in the elderly.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karin Stiasny Research Topics

Disease

23	Infections 03/2022 - 10/2006
12	Tick-Borne Encephalitis (Encephalitis, Tick Borne) 08/2021 - 01/2012
8	COVID-19 01/2022 - 01/2020
7	Yellow Fever 01/2020 - 06/2012
6	Dengue (Dengue Fever) 01/2021 - 06/2012
3	Zika Virus Infection 01/2020 - 01/2018
3	Flavivirus Infections 01/2018 - 12/2012
3	Japanese Encephalitis 01/2017 - 06/2012
2	Virus Diseases (Viral Diseases) 01/2022 - 01/2020
2	Reinfection 01/2021 - 11/2020
1	Asymptomatic Diseases 01/2022
1	Encephalitis (Encephalitis, Rasmussen) 03/2021
1	Exanthema (Rash) 01/2021
1	Hemorrhage 01/2021
1	Measles 01/2021
1	Asymptomatic Infections 01/2020
1	Obesity 01/2020
1	Vaccine-Preventable Diseases 01/2020
1	Human Influenza (Influenza) 09/2013
1	Hepatitis B 09/2013
1	Genetic Predisposition to Disease (Genetic Predisposition) 09/2013
1	Severe Dengue 06/2012
1	Fever (Fevers) 06/2012
1	Parkinson Disease (Parkinson's Disease) 05/2002
1	Sleepiness 05/2002

Drug/Important Bio-Agent (IBA)

18	AntibodiesIBA 01/2022 - 10/2006
15	VaccinesIBA 01/2022 - 01/2012
11	Proteins (Proteins, Gene)FDA Link 03/2022 - 07/2014
7	Immunoglobulin G (IgG)IBA 01/2022 - 01/2020
6	EpitopesIBA 01/2022 - 07/2014
6	Neutralizing AntibodiesIBA 01/2022 - 12/2014
6	Immunoglobulin M (IgM)IBA 01/2021 - 01/2020
4	AntigensIBA 01/2022 - 01/2020
3	Peptides (Polypeptides)IBA 01/2022 - 07/2014
3	CytokinesIBA 08/2021 - 09/2013
3	Viral Envelope ProteinsIBA 01/2017 - 12/2014
2	mRNA VaccinesIBA 01/2022 - 01/2021
2	Immunoglobulin A (IgA)IBA 01/2021 - 01/2021
2	Interleukin-2 (IL2)IBA 01/2020 - 09/2013
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2018 - 01/2018
1	Protein SIBA 01/2022
1	EnzymesIBA 01/2021
1	Immunoglobulins (Immunoglobulin)IBA 01/2021
1	ImmunosorbentsIBA 01/2021
1	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 01/2021
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2021
1	Nucleocapsid ProteinsIBA 01/2021
1	Chemokine CXCL10IBA 11/2020
1	LeptinIBA 01/2020
1	InterferonsIBA 01/2020
1	AllergensIBA 11/2018
1	LipidsIBA 09/2017
1	Liposomes (Liposome)IBA 09/2017
1	Biological ProductsIBA 09/2017
1	Broadly Neutralizing AntibodiesIBA 01/2016
1	Membrane Proteins (Integral Membrane Proteins)IBA 07/2014
1	Inactivated VaccinesIBA 07/2014
1	Aluminum Hydroxide (Algeldrate)FDA Link 11/2013
1	Influenza Vaccines (Influenza Vaccine)FDA Link 09/2013
1	Interleukin-10 (Interleukin 10)IBA 09/2013
1	HLA-DR Antigens (HLA-DR)IBA 09/2013
1	Dengue VaccinesIBA 06/2012
1	Attenuated VaccinesIBA 06/2012
1	Dopamine Agonists (Dopamine Agonist)IBA 05/2002
1	Levodopa (L Dopa)FDA LinkGeneric 05/2002

Therapy/Procedure

2	Therapeutics 01/2020 - 05/2002
1	Hematopoietic Stem Cell Transplantation 08/2021
1	Personal Protective Equipment 01/2021
1	Subcutaneous Injections 01/2021
1	Immunotherapy 11/2018
1	Blood Transfusion (Blood Transfusions) 10/2017